Outset Medical Posts $18M Q2 Loss, Revenue and Outlook in Focus
OM sits 77% above its 52-week low of $3.
Summary
Outset Medical reported a Q2 net loss of $18 million. The headline lacks revenue, margin, or guidance details, but the loss figure alone is a material data point for a company with a ~$96M market cap. This follows a recent $40M HCA contract win and an executive departure in May, adding to a mixed operational picture. The market will react to the full earnings release for revenue trends and any update to the full-year outlook.
At the time of this announcement, OM was trading at $5.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $96.3M. The 52-week trading range was $3.00 to $17.20. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.